FDA Calendar for Adventrx Pharmaceuticals, Inc. (ANX)

| Register (free)
DVENTRX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates for the treatment of cancer. Its lead product candidates include ANX-530, a novel emulsion formulation of chemotherapy drug vinorelbine to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, as well as to treat advanced or metastatic breast cancer; and ANX-514, a novel emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. The company was founded in 1995 is based in San Diego, California.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
This company currently does not have any drugs. If you would like to create one please click here.


Events

No future events listed at this time, please check back later.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

ANX

$0.67
0.0051 +0.76%
2/3/2012 4:00:00 PM

Sponsors

Other Links